Read more at MarketWatch.
Novo Nordisk says starter doses of weight-loss drug surge as company hikes financial outlook
Date: |
Sort by
Filter
Date
Items per page
-
Roche says weight loss drug shows promising results in early trial
The weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after 24 weeks in the phase one trial.CNBC - Business -
Roche Climbs After Weight-Loss Drug Shows Efficacy
Roche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial, giving the company a boost in its bid to catch up to Novo Nordisk and Eli Lilly in a class of medicines that has shaken up everything from pharma ...The Wall Street Journal - Business -
Canada Goose jumps 16% after the company reports growth surge in China
Shares of Canada Goose soared 16% on Thursday after the apparel company reported better-than-expected revenue and earnings for its fiscal fourth quarter.CNBC - Business - China -
'No financial room,' German minister says as tax revenues drop
Yahoo News - World - Germany -
Denmark Raises Growth Forecast as Novo Expands Output
Yahoo News - World -
EasyJet expects summer demand to lift earnings after a narrowed first-half loss, but the airline's outlook for the end of the year weighed on its shares.
EasyJet expects summer demand to lift earnings after a narrowed first-half loss, but the airline’s outlook for the end of the year weighed on its shares.The Wall Street Journal - World -
Financial Services Roundup: Market Talk
Read about Canada Mortgage and Housing Corp., Allianz, ABN Amro and more in the latest Market Talks covering Financial Services.The Wall Street Journal - World -
Reddit shares surge as it strikes content deal with OpenAI
Agreement comes as competition for high-quality data to underpin AI models intensifiesFinancial Times - Business -
Surging Hospital Prices Are Helping Keep Inflation High
Hospital prices last month notched their highest increase in 13 years. The hikes are a reason U.S. inflation remains elevated.The Wall Street Journal - Business -
Brazil's government hikes 2024 GDP forecast, sees higher inflation, terminal rate
Yahoo News - World - Brazil
More from MarketWatch
-
Technology stocks are once again leading the way in 2024. Why these ETFs tell a different story.
U.S. stocks are rallying in 2024, but some of the most popular ETFs tracking key sectors haven’t kept pace, leading to significant gaps between their returns and the indexes they are designed to mirror.MarketWatch - Business -
Bank of America forecasts an upturn after the worst performance for 30-year bonds in over 100 years
The total return on 30-year bonds has declined by 45% since April 2020, the worst four-year loss in over 100 years, according to strategists at Bank of America.MarketWatch - Business -
‘An AI-fueled equity bubble’ will see big tech lead the charge in coming months
Big tech can once again be the market’s crown jewels says Capital EconomicsMarketWatch - Business -
Why a shift in market environment may make an ‘accident’ more likely
Markets are returning to the traditional relationship between stocks and volatility that leaves markets more prone to an accident, according to one market observer.MarketWatch - Business -
‘I was hospitalized due to blood poisoning from a feral cat bite — and the copay wiped out my savings’: Should I cash out my $12,000 life-insurance policy?
“I am now in my 50s and have no family. I have no children and no siblings left.”MarketWatch - Business